Singapore, March 9 -- US-based BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), has established a joint venture with Cenra API Solutions, also as known as Chunghwa Chemical Synthesis & Biotech (CCSB), a leading pharmaceutical chemical manufacturer in Taiwan since 1964, to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.

The joint venture will see BioDuro's strengths in early-stage drug development integrated with Cenra's expertise in commercial scale GMP API manufacturing, providing global clients with an end-to-end API solution from early development through to commercial-scal...